连接组织疾病的无菌性脑膜炎中的抗体:一个病例报告
Sreevinishaa Ravichandran1, J Kumar1, Nirmala Devi Chandrasekaran1
1General Medicine, Sri Ramasamy Memorial (SRM) Medical College Hospital and Research Centre, Chennai, IND.
Cureus
|June 21, 2024
概括
混合结合组织疾病 (MCTD) 是一种罕见的自身免疫性疾病. 早期诊断不寻常的症状,如头痛,对于有效的治疗和MCTD患者的更好的结果至关重要.
科学领域:
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
- 神经学 神经学
背景情况:
- 混合连接组织疾病 (MCTD) 是一种罕见的自身免疫性风湿性疾病,其特征是其他自身免疫性疾病的重叠特征.
- 它与抗U1-RNP抗体密切相关,可以影响多个器官,呈现出不同的临床表现.
- 常见的症状包括关节疼痛,雷诺氏现象和食道动力障碍,而更罕见,更严重的表现包括肺高血压和中枢神经系统 (CNS) 的参与.
研究的目的:
- 强调在出现异常神经症状的患者中考虑MCTD的重要性,例如持续的头痛.
- 强调需要在自身免疫性疾病中进行彻底的差异诊断,这些疾病的症状可以模仿其他疾病.
- 要强调延迟诊断和不适当治疗对患者预后的影响.
主要方法:
- 案例报告介绍了一个年轻的女性患有持续性头痛.
- 关于MCTD的神经表现的文献综述.
- 讨论诊断挑战和对自身免疫性疾病中头痛的差异诊断.
主要成果:
- 该案例说明了头痛如何掩盖潜在的未被诊断的结缔组织疾病,如MCTD.
- 神经症状,包括三角神经疼痛和无菌性脑膜炎,约有10%的MCTD患者报告.
- 对神经症状进行不适当的抗生素治疗可能会延迟诊断,并使MCTD的预后恶化.
结论:
- 潜在的自身免疫性疾病患者的持续和不寻常的症状,特别是头痛,需要全面评估.
- 精细的差异诊断对于识别MCTD和其他具有神经症状的自身免疫性疾病至关重要.
- 及时和准确的诊断对于启动适当的治疗和在MCTD患者中获得良好的结果至关重要.
更多相关视频
11:10Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study
Published on: June 29, 2016
14.1K
08:20Hippocampal Neuronal Cultures to Detect and Study New Pathogenic Antibodies Involved in Autoimmune Encephalitis
Published on: June 2, 2022
3.2K
相关概念视频
Myasthenia Gravis: Overview and Treatment
1.3K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.3K
Myasthenia Gravis: Diagnostic Tests
764
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
764
